Ethos Cannabis expands into Ohio with cultivation and dispensary acquisitions

Ethos Cannabis has announced its acquisition of two cannabis businesses in the Ohio medical cannabis market. The acquisition of these businesses will further the Ethos footprint westward.

Previously, Ethos’s footprint included retail and production operations in Massachusetts, Pennsylvania, and Maryland. This expansion into the Ohio market lets the company continue advancing its intent to deliver high-quality cannabis to consumers across the United States.

In December 2021, Ethos acquired Agri-Med Ohio, a Tier II Medical Cultivation Licensee located in Langsville. Agri-Med Ohio is being integrated into the Ethos platform to further enhance and expand operations. Ethos will continue to produce the Meigs County line of products and looks forward to introducing additional products to the Ohio market in the future.

In April 2022, Ethos acquired About Wellness Ohio, a medical dispensary licensee located in the Greater Cincinnati Area in Lebanon. The dispensary will continue to operate as About Wellness Ohio, but the company plans to transition the dispensary to the Ethos Cannabis brand later in 2022. Ethos is focused on continuing to provide all the positive attributes of the About Wellness Ohio experience while launching attractive enhancements to continue to improve the patient experience.

“The acquisitions in Ohio position us to continue extending our retail experience and products to benefit more patients. As one of the most populated states in the U.S., Ohio is a natural progression for us as we further expand our operations. We are thrilled to continue leading this industry forward in a manner that puts health and wellness at the forefront,” said David Clapper, Ethos CEO.

For more information:
Ethos Cannabis 

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.